跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 183 条关于
“epilepsies”
全部
183
临床试验
117
药物
2
机构
2
资讯
62
9个月前
Lundbeck's Bexicaserin Shows Sustained Seizure Reduction in Rare Childhood Epilepsies After Two Years of Treatment
6个月前
Angelini Pharma Partners with Quiver Bioscience in $120M Deal to Advance AI-Driven Therapies for Rare Genetic Epilepsies
去年
Antisense Oligonucleotide Therapies Show Promise in Treating Genetic Epilepsies
2年前
Bright Minds Biosciences Initiates Phase 2 Trial of BMB-101 for Drug-Resistant Epilepsies
去年
4-Phenylbutyrate Shows Promise in Treating Genetic Epilepsy in Children
去年
Ananda Developments' Cannabinoid Medicines to be Used in NHS Epilepsy Trials
去年
Ananda Developments' Cannabinoid Medicines to Undergo Phase III Trials for Refractory Epilepsy
去年
Ananda Developments Advances Cannabinoid Medicines in Phase III Epilepsy Trials
去年
Lundbeck to Acquire Longboard for $2.6 Billion, Bolstering Neuro-Rare Disease Pipeline
11个月前
Ovid Therapeutics Reports Positive Phase 1 Results for OV329 in Drug-Resistant Epilepsy
第 1 页,共 7 页
上一页
下一页